FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978070868> ?p ?o ?g. }

• W1978070868 endingPage "137" @default.
• W1978070868 startingPage "128" @default.
• W1978070868 abstract "Mitogen-activated protein kinases (MAPKs) are a family of ubiquitous eukaryotic signal transduction enzymes which link extracellular stimuli to intracellular gene expression pathways. While several three-tiered MAPK cascades have been elucidated in mammals, the prototypical pathway involves a network of proteins and kinases including the Rat sarcoma protein (Ras), mitogen-activated protein kinase kinase kinase (Raf or MAP3K), mitogen-activated protein kinase kinase (MEK or MAP2K), and extracellular signal regulated protein kinase (ERK or MAPK). This MAPK cascade (the Ras/Raf/MEK/ERK pathway) is a receptor tyrosine kinase mediated signaling pathway that regulates cell proliferation, cell cycle progression, and cell migration. There are multiple molecular mechanisms of interaction and activation between the upstream nodes of the Ras/Raf/MEK/ERK cascade and other cell signaling pathways, all ultimately leading to the activation of the nuclear transcription factor ERK. Important downstream targets include MEK1/2, which comprise the final step leading to ERK transcription factor activation. While multiple conduits exist to activate ERK upstream of MEK, there is little redundancy downstream. Located at this pivotal intersection between a limited number of upstream activators and its exclusive downstream targets, MEK is an appealing molecular target of novel cancer therapies. MEK inhibitors are small molecules that inhibit MEK phosphorylation by binding to a pocket adjacent to the ATP binding site, decreasing both the amount of MEK activity, and the quantity of activated ERK in the cell. Unique allosteric noncompetitive binding sites of MEK inhibitors allow specific targeting of MEK enzymes and prevent cross-activation of other serine/threonine protein kinases through the conserved ATP binding site. This paper reviews the translational evidence in favor of MEK inhibitors in cancer, their role in gynecologic malignancies, and details regarding the status of the fourteen MEK inhibitors currently being clinically tested: trametinib, selumetinib, pimasertib, refametinib, PD-0325901, MEK162, TAK733, RO5126766, WX-554, RO4987655, cobimetinib, AZD8330, MSC2015103B, and ARRY-300." @default.
• W1978070868 created "2016-06-24" @default.
• W1978070868 creator A5005580927 @default.
• W1978070868 creator A5033186957 @default.
• W1978070868 creator A5068479857 @default.
• W1978070868 date "2014-04-01" @default.
• W1978070868 modified "2023-10-14" @default.
• W1978070868 title "MEK1/2 inhibitors in the treatment of gynecologic malignancies" @default.
• W1978070868 cites W1494491432 @default.
• W1978070868 cites W1555772346 @default.
• W1978070868 cites W1592490241 @default.
• W1978070868 cites W1967187359 @default.
• W1978070868 cites W1967913221 @default.
• W1978070868 cites W1971380103 @default.
• W1978070868 cites W1974091059 @default.
• W1978070868 cites W1981602821 @default.
• W1978070868 cites W1993840739 @default.
• W1978070868 cites W1994424553 @default.
• W1978070868 cites W1996405087 @default.
• W1978070868 cites W2010685617 @default.
• W1978070868 cites W2016382281 @default.
• W1978070868 cites W2017408894 @default.
• W1978070868 cites W2018789635 @default.
• W1978070868 cites W2047514293 @default.
• W1978070868 cites W2054918837 @default.
• W1978070868 cites W2055248710 @default.
• W1978070868 cites W2056785598 @default.
• W1978070868 cites W2057058351 @default.
• W1978070868 cites W2061339803 @default.
• W1978070868 cites W2066555699 @default.
• W1978070868 cites W2070686081 @default.
• W1978070868 cites W2073083472 @default.
• W1978070868 cites W2079822637 @default.
• W1978070868 cites W2080686146 @default.
• W1978070868 cites W2091107854 @default.
• W1978070868 cites W2091935713 @default.
• W1978070868 cites W2100738068 @default.
• W1978070868 cites W2106439593 @default.
• W1978070868 cites W2114784462 @default.
• W1978070868 cites W2114852376 @default.
• W1978070868 cites W2116780606 @default.
• W1978070868 cites W2118523851 @default.
• W1978070868 cites W2118549562 @default.
• W1978070868 cites W2119478133 @default.
• W1978070868 cites W2120203403 @default.
• W1978070868 cites W2124662474 @default.
• W1978070868 cites W2127037900 @default.
• W1978070868 cites W2127180214 @default.
• W1978070868 cites W2129400742 @default.
• W1978070868 cites W2130979878 @default.
• W1978070868 cites W2136474966 @default.
• W1978070868 cites W2148914096 @default.
• W1978070868 cites W2150798124 @default.
• W1978070868 cites W2154841567 @default.
• W1978070868 cites W2160181672 @default.
• W1978070868 cites W2161817637 @default.
• W1978070868 cites W2162147795 @default.
• W1978070868 cites W2163188200 @default.
• W1978070868 cites W2172099875 @default.
• W1978070868 cites W2325793456 @default.
• W1978070868 cites W2590813934 @default.
• W1978070868 cites W4237425342 @default.
• W1978070868 doi "https://doi.org/10.1016/j.ygyno.2014.01.008" @default.
• W1978070868 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24434059" @default.
• W1978070868 hasPublicationYear "2014" @default.
• W1978070868 type Work @default.
• W1978070868 sameAs 1978070868 @default.
• W1978070868 citedByCount "86" @default.
• W1978070868 countsByYear W19780708682014 @default.
• W1978070868 countsByYear W19780708682015 @default.
• W1978070868 countsByYear W19780708682016 @default.
• W1978070868 countsByYear W19780708682017 @default.
• W1978070868 countsByYear W19780708682018 @default.
• W1978070868 countsByYear W19780708682019 @default.
• W1978070868 countsByYear W19780708682020 @default.
• W1978070868 countsByYear W19780708682021 @default.
• W1978070868 countsByYear W19780708682022 @default.
• W1978070868 countsByYear W19780708682023 @default.
• W1978070868 crossrefType "journal-article" @default.
• W1978070868 hasAuthorship W1978070868A5005580927 @default.
• W1978070868 hasAuthorship W1978070868A5033186957 @default.
• W1978070868 hasAuthorship W1978070868A5068479857 @default.
• W1978070868 hasConcept C124160383 @default.
• W1978070868 hasConcept C132149769 @default.
• W1978070868 hasConcept C137361374 @default.
• W1978070868 hasConcept C184235292 @default.
• W1978070868 hasConcept C185592680 @default.
• W1978070868 hasConcept C2909504400 @default.
• W1978070868 hasConcept C502942594 @default.
• W1978070868 hasConcept C57074206 @default.
• W1978070868 hasConcept C62478195 @default.
• W1978070868 hasConcept C86803240 @default.
• W1978070868 hasConcept C90934575 @default.
• W1978070868 hasConcept C95444343 @default.
• W1978070868 hasConcept C97029542 @default.
• W1978070868 hasConcept C99405784 @default.
• W1978070868 hasConceptScore W1978070868C124160383 @default.
• W1978070868 hasConceptScore W1978070868C132149769 @default.

• next